Ceftazidime Injection, Powder, For Solution
Product Images NDC 25021-129

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ceftazidime (NDC 25021-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cef0f 0010 01

Chemical structure of Ceftazidime, showing its molecular components and arrangement, including associated water molecules (5H2O). The diagram details the specific bonds and atoms present in the active ingredient.*

FDA Label Image

Cef0f 0010 02

Ceftazidime 6 g per bottle vial label for injection, USP, by Sagent Pharmaceuticals. The label indicates this is a pharmacy bulk package and not for direct infusion, requiring further dilution. It states storage temperature and preparation instructions, with the NDC 25021-129 clearly visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.